Stenotrophomonas maltophilia is a Gram-negative pathogen with emerging nosocomial incidence [1]. It has been associated with several clinical syndromes, primarily in relation to the opportunistic infection of immunocompromised patients. Although not an inherently virulent pathogen, its ability to colonise respiratory-tract epithelial cells and medical-device surfaces makes it a ready coloniser of hospital settings.